Gerresheimer (GXIN) AI Stock Analysis

Gerresheimer

(BMV:GXIN)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Steady Revenue GrowthRevenue growth across several years indicates expanding demand for Gerresheimer’s pharmaceutical packaging and delivery products. Continued top-line expansion provides a durable base for operating leverage and supports investment in specialized products, customer programs, and future capacity.

Negative Factors

Swing to Net LossThe shift from consistent operating profitability in 2020–2024 to substantial EBIT and net losses in 2025 is a material deterioration in earnings quality. If not reversed, weaker profitability could reduce reinvestment capacity and undermine returns from the company’s growing revenue base.

Gerresheimer (GXIN) vs. SPDR S&P 500 ETF (SPY)

Market Cap: MXN 23.22B
Dividend Yield: 0.13%
Average Volume (3M): 1,142
Price to Earnings (P/E): -2.8
Beta (1Y): 0.29
Revenue Growth: 15.66%
EPS Growth: -649.58%
Country: Mexico
Employees: 13,301
Sector: General
Sector Strength: 55
Industry: Medical - Instruments & Supplies

Gerresheimer Business Overview & Revenue Model

Company Description

Gerresheimer AG, founded in 1864 and based in Düsseldorf, Germany, is a global supplier specializing in the production and sale of packaging solutions and sophisticated drug delivery systems. The company operates through three distinct divisions. Its...

Gerresheimer Peers Comparison

Overall Rating

Financial Indicators

MX:GXIN against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%

* General Sector Average

Performance Comparison

MX:GXIN and its peers over the selected period
Show on chart	Ticker	Company Name	Price	Change	% Change
	MX:GXIN	Gerresheimer AG	672.05	-977.70	-59.26%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Gerresheimer AI Stock Analysis